TreeWAS – Variant ID: rs5003154

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?

Click here to show this figure without filtering.

Click on a node to zoom (except terminal nodes).

Download this figure in format

Results table

Term	Risk posterior probability	No effect posterior probability	Protective posterior probability
C67.9 Bladder, unspecified	0.903	0.097	0.000
C67 Malignant neoplasm of bladder	0.901	0.099	0.000
H33.3 Retinal breaks without detachment	0.846	0.154	0.000
H33 Retinal detachments and breaks	0.845	0.155	0.000
C67.3 Anterior wall of bladder	0.840	0.160	0.000
C67.2 Lateral wall of bladder	0.840	0.160	0.000
C67.6 Ureteric orifice	0.837	0.163	0.000
H33.5 Other retinal detachments	0.790	0.210	0.000
H30-H36 Disorders of choroid and retina	0.786	0.214	0.000
C67.0 Trigone of bladder	0.778	0.222	0.000
H35 Other retinal disorders	0.767	0.233	0.000
H34 Retinal vascular occlusions	0.746	0.254	0.000
H35.8 Other specified retinal disorders	0.743	0.257	0.000
H33.4 Traction detachment of retina	0.731	0.269	0.000
C67.4 Posterior wall of bladder	0.729	0.271	0.000
H33.0 Retinal detachment with retinal break	0.717	0.283	0.000
H35.9 Retinal disorder, unspecified	0.713	0.287	0.000
H35.4 Peripheral retinal degeneration	0.699	0.301	0.000
H34.8 Other retinal vascular occlusions	0.694	0.306	0.000
C67.5 Bladder neck	0.694	0.306	0.000
H33.1 Retinoschisis and retinal cysts	0.680	0.320	0.000
C67.7 Urachus	0.646	0.354	0.000
H34.1 Central retinal artery occlusion	0.636	0.364	0.000
H35.7 Separation of retinal layers	0.635	0.365	0.000
C67.8 Overlapping lesion of bladder	0.633	0.367	0.000
C67.1 Dome of bladder	0.626	0.374	0.000
H33.2 Serous retinal detachment	0.582	0.418	0.000
H35.2 Other proliferative retinopathy	0.570	0.430	0.000
H32 Chorioretinal disorders in diseases classified elsewhere	0.563	0.436	0.000
H35.1 Retinopathy of prematurity	0.550	0.450	0.000
H34.2 Other retinal artery occlusions	0.540	0.460	0.000
H34.0 Transient retinal artery occlusion	0.535	0.465	0.000
H34.9 Retinal vascular occlusion, unspecified	0.523	0.477	0.000
H30 Chorioretinal inflammation	0.522	0.477	0.000
H35.6 Retinal haemorrhage	0.495	0.505	0.000
H31 Other disorders of choroid	0.462	0.538	0.000
H32.8 Other chorioretinal disorders in diseases classified elsewhere	0.404	0.596	0.000
H32.0 Chorioretinal inflammation in infectious and parasitic diseases classified elsewhere	0.404	0.596	0.000
H35.0 Background retinopathy and retinal vascular changes	0.403	0.597	0.000
C64-C68 Malignant neoplasms of urinary tract	0.382	0.618	0.000
H31.3 Choroidal haemorrhage and rupture	0.379	0.621	0.000
H30.8 Other chorioretinal inflammations	0.375	0.625	0.000
H30.1 Disseminated chorioretinal inflammation	0.375	0.625	0.000
H30.0 Focal chorioretinal inflammation	0.375	0.625	0.000
H30.2 Posterior cyclitis	0.367	0.633	0.000
C66 Malignant neoplasm of ureter	0.349	0.651	0.000
H36 Retinal disorders in diseases classified elsewhere	0.346	0.654	0.000
H30.9 Chorioretinal inflammation, unspecified	0.343	0.657	0.000
H31.4 Choroidal detachment	0.331	0.669	0.000
H31.2 Hereditary choroidal dystrophy	0.331	0.669	0.000
H31.9 Disorder of choroid, unspecified	0.321	0.678	0.000
H31.8 Other specified disorders of choroid	0.317	0.683	0.000
C68 Malignant neoplasm of other and unspecified urinary organs	0.310	0.690	0.000
H35.5 Hereditary retinal dystrophy	0.286	0.713	0.001
H31.0 Chorioretinal scars	0.271	0.729	0.000
H31.1 Choroidal degeneration	0.252	0.747	0.000
H36.8 Other retinal disorders in diseases classified elsewhere	0.248	0.752	0.000
C68.0 Urethra	0.245	0.755	0.000
C68.9 Urinary organ, unspecified	0.240	0.760	0.000
C68.8 Overlapping lesion of urinary organs	0.222	0.778	0.000
C68.1 Paraurethral glands	0.222	0.778	0.000
C65 Malignant neoplasm of renal pelvis	0.214	0.786	0.000
H35.3 Degeneration of macula and posterior pole	0.148	0.852	0.000
C64 Malignant neoplasm of kidney, except renal pelvis	0.054	0.946	0.000
H36.0 Diabetic retinopathy	0.030	0.970	0.000
N99.3 Prolapse of vaginal vault after hysterectomy	0.000	0.971	0.029
N99 Postprocedural disorders of genito-urinary system, not elsewhere classified	0.000	0.974	0.026
N99.0 Postprocedural renal failure	0.000	0.975	0.025
N99.5 Malfunction of external stoma of urinary tract	0.000	0.976	0.024
N99.2 Postprocedural adhesions of vagina	0.000	0.978	0.022
N99.9 Postprocedural disorder of genito-urinary system, unspecified	0.000	0.980	0.020
D23.5 Skin of trunk	0.019	0.981	0.000
K56.2 Volvulus	0.019	0.981	0.000
N99.8 Other postprocedural disorders of genito-urinary system	0.000	0.983	0.017
N99.4 Postprocedural pelvic peritoneal adhesions	0.000	0.983	0.017
N99.1 Postprocedural urethral stricture	0.000	0.985	0.014
T43.5 Other and unspecified antipsychotics and neuroleptics	0.013	0.987	0.000
T43.3 Phenothiazine antipsychotics and neuroleptics	0.012	0.988	0.000
T43 Poisoning by psychotropic drugs, not elsewhere classified	0.011	0.989	0.000
N99-N99 Other disorders of the genitourinary system	0.000	0.989	0.011
G24.9 Dystonia, unspecified	0.010	0.990	0.000
T43.9 Psychotropic drug, unspecified	0.010	0.990	0.000
T43.1 Monoamine-oxidase-inhibitor antidepressants	0.009	0.990	0.000
T43.6 Psychostimulants with abuse potential	0.009	0.991	0.000
Z08.7 Follow-up examination after combined treatment for malignant neoplasm	0.009	0.991	0.000
T43.4 Butyrophenone and thioxanthene neuroleptics	0.009	0.991	0.000
T43.8 Other psychotropic drugs, not elsewhere classified	0.008	0.991	0.000
G24 Dystonia	0.008	0.992	0.000
G24.3 Spasmodic torticollis	0.008	0.992	0.000
T43.0 Tricyclic and tetracyclic antidepressants	0.008	0.992	0.000
G44.2 Tension-type headache	0.000	0.992	0.008
G24.8 Other dystonia	0.007	0.993	0.000
N05.9 Unspecified	0.007	0.993	0.000
G24.1 Idiopathic familial dystonia	0.007	0.993	0.000
G24.0 Drug-induced dystonia	0.006	0.993	0.000
S46.0 Injury of tendon of the rotator cuff of shoulder	0.006	0.994	0.000
H18.5 Hereditary corneal dystrophies	0.000	0.994	0.006
G24.4 Idiopathic orofacial dystonia	0.006	0.994	0.000
G24.2 Idiopathic nonfamilial dystonia	0.006	0.994	0.000
T46.6 Antihyperlipidaemic and antiarteriosclerotic drugs	0.006	0.994	0.000
N05 Unspecified nephritic syndrome	0.006	0.994	0.000
G44.4 Drug-induced headache, not elsewhere classified	0.000	0.994	0.006
N05.5 Diffuse mesangiocapillary glomerulonephritis	0.006	0.994	0.000
T46 Poisoning by agents primarily affecting the cardiovascular system	0.006	0.994	0.000
G44 Other headache syndromes	0.000	0.994	0.006
N05.7 Diffuse crescentic glomerulonephritis	0.006	0.994	0.000
H18.8 Other specified disorders of cornea	0.000	0.994	0.006
M07.39 Other psoriatic arthropathies (Site unspecified)	0.000	0.994	0.006
H18.9 Disorder of cornea, unspecified	0.000	0.994	0.005
T46.4 Angiotensin-converting-enzyme inhibitors	0.005	0.995	0.000
T46.3 Coronary vasodilators, not elsewhere classified	0.005	0.995	0.000
H18 Other disorders of cornea	0.000	0.995	0.005
T36-T50 Poisoning by drugs, medicaments and biological substances	0.005	0.995	0.000
G44.0 Cluster headache syndrome	0.000	0.995	0.005
T37 Poisoning by other systemic anti-infectives and antiparasitics	0.005	0.995	0.000
G24.5 Blepharospasm	0.005	0.995	0.000
T37.8 Other specified systemic anti-infectives and antiparasitics	0.005	0.995	0.000
N05.2 Diffuse membranous glomerulonephritis	0.005	0.995	0.000
H18.6 Keratoconus	0.000	0.995	0.005
R90.8 Other abnormal findings on diagnostic imaging of central nervous system	0.005	0.995	0.000
N05.6 Dense deposit disease	0.005	0.995	0.000
N05.4 Diffuse endocapillary proliferative glomerulonephritis	0.005	0.995	0.000
N05.0 Minor glomerular abnormality	0.005	0.995	0.000
G44.1 Vascular headache, not elsewhere classified	0.000	0.995	0.004
T46.9 Other and unspecified agents primarily affecting the cardiovascular system	0.004	0.995	0.000
T48 Poisoning by agents primarily acting on smooth and skeletal muscles and the respiratory system	0.004	0.995	0.000
H18.1 Bullous keratopathy	0.000	0.995	0.004
N05.8 Other	0.004	0.995	0.000
T46.8 Antivaricose drugs, including sclerosing agents	0.004	0.995	0.000
T46.7 Peripheral vasodilators	0.004	0.995	0.000
T50 Poisoning by diuretics and other and unspecified drugs, medicaments and biological substances	0.005	0.995	0.000
N05.1 Focal and segmental glomerular lesions	0.004	0.996	0.000
T46.0 Cardiac-stimulant glycosides and drugs of similar action	0.004	0.996	0.000
T49 Poisoning by topical agents primarily affecting skin and mucous membrane and by ophthalmological, otorhinolarygological and dental drugs	0.004	0.996	0.000
T44 Poisoning by drugs primarily affecting the autonomic nervous system	0.004	0.996	0.000
T36 Poisoning by systemic antibiotics	0.004	0.996	0.000
R50.0 Fever with chills	0.004	0.996	0.000
E21.0 Primary hyperparathyroidism	0.004	0.996	0.000
G44.3 Chronic posttraumatic headache	0.000	0.996	0.004
T46.2 Other antidysrhythmic drugs, not elsewhere classified	0.004	0.996	0.000
M80.00 Postmenopausal osteoporosis with pathological fracture (Multiple sites)	0.004	0.996	0.000
T37.2 Antimalarials and drugs acting on other blood protozoa	0.004	0.996	0.000
Z88.5 Personal history of allergy to narcotic agent	0.000	0.996	0.004
N05.3 Diffuse mesangial proliferative glomerulonephritis	0.004	0.996	0.000
T48.5 Anti-common-cold drugs	0.004	0.996	0.000
T41 Poisoning by anaesthetics and therapeutic gases	0.004	0.996	0.000
R47.0 Dysphasia and aphasia	0.004	0.996	0.000
T45 Poisoning by primarily systemic and haematological agents, not elsewhere classified	0.004	0.996	0.000
T46.5 Other antihypertensive drugs, not elsewhere classified	0.004	0.996	0.000
N30.3 Trigonitis	0.000	0.996	0.004
T45.0 Antiallergic and antiemetic drugs	0.004	0.996	0.000
T37.9 Systemic anti-infective and antiparasitic, unspecified	0.004	0.996	0.000
T37.5 Antiviral drugs	0.004	0.996	0.000
T37.4 Anthelminthics	0.004	0.996	0.000
T37.3 Other antiprotozoal drugs	0.004	0.996	0.000
T37.1 Antimycobacterial drugs	0.004	0.996	0.000
T37.0 Sulphonamides	0.004	0.996	0.000
Z85.5 Personal history of malignant neoplasm of urinary tract	0.004	0.996	0.000
H18.2 Other corneal oedema	0.000	0.996	0.004
H18.7 Other corneal deformities	0.000	0.996	0.004
T50.1 Loop [high-ceiling] diuretics	0.004	0.996	0.000
H18.0 Corneal pigmentations and deposits	0.000	0.996	0.004
J13 Pneumonia due to Streptococcus pneumoniae	0.004	0.996	0.000
T50.4 Drugs affecting uric acid metabolism	0.004	0.996	0.000
T49.0 Local antifungal, anti-infective and anti-inflammatory drugs, not elsewhere classified	0.004	0.996	0.000
I98.2 Oesophageal varices in diseases classified elsewhere	0.000	0.996	0.004
T44.9 Other and unspecified drugs primarily affecting the nervous system	0.004	0.996	0.000
H18.3 Changes in corneal membranes	0.000	0.996	0.003
T50.9 Other and unspecified drugs, medicaments and biological substances	0.004	0.996	0.000
G44.8 Other specified headache syndromes	0.000	0.996	0.003
T36.0 Penicillins	0.003	0.996	0.000
T44.3 Other parasympatholytics [anticholinergics and antimuscarines] and spasmolytics, not elsewhere classified	0.003	0.996	0.000
N89.9 Noninflammatory disorder of vagina, unspecified	0.004	0.996	0.000
T44.6 Alpha-Adrenoreceeptor antagonists, not elsewhere classified	0.003	0.996	0.000
T48.7 Other and unspecified agents primarily acting on the respiratory system	0.003	0.996	0.000
T48.4 Expectorants	0.003	0.996	0.000
T48.3 Antitussives	0.003	0.996	0.000
T48.2 Other and unspecified agents primarily acting on muscles	0.003	0.996	0.000
T48.1 Skeletal muscle relaxants [neuromuscular blocking agents]	0.003	0.996	0.000
T48.0 Oxytocic drugs	0.003	0.996	0.000
T50.7 Analeptics and opioid receptor antagonists	0.003	0.996	0.000
T50.5 Appetite depressants	0.003	0.996	0.000
T50.3 Electrolytic, caloric and water-balance agents	0.003	0.996	0.000
T50.0 Mineralocorticoids and their antagonists	0.003	0.996	0.000
T50.6 Antidotes and chelating agents, not elsewhere classified	0.003	0.997	0.000
T49.9 Topical agent, unspecified	0.003	0.997	0.000
T49.8 Other topical agents	0.003	0.997	0.000
T49.7 Dental drugs, topically applied	0.003	0.997	0.000
T49.6 Otorhinolaryngological drugs and preparations	0.003	0.997	0.000
T49.5 Ophthalmological drugs and preparations	0.003	0.997	0.000
T49.4 Keratolytics, keratoplastics and other hair treatment drugs and preparations	0.003	0.997	0.000
T49.3 Emollients, demulcents and protectants	0.003	0.997	0.000
T49.2 Local astringents and local detergents	0.003	0.997	0.000
T49.1 Antipruritics	0.003	0.997	0.000
T44.8 Centrally acting and afrenergic-neuron-blocking agents, not elsewhere classified	0.003	0.997	0.000
T44.5 Predominantly Beta-adrenoreceptor agonists, not elsewhere classified	0.003	0.997	0.000
T44.4 Predominantly Alpha-adrenoreceptor agonists, not elsewhere classified	0.003	0.997	0.000
T44.2 Ganglionic blocking drugs, not elsewhere classified	0.003	0.997	0.000
T44.1 Other parasympathomimetics [cholinergics]	0.003	0.997	0.000
T44.0 Anticholinesterase agents	0.003	0.997	0.000
T48.6 Antiasthmatics, not elsewhere classified	0.003	0.997	0.000
T36.9 Systemic antibiotic, unspecified	0.003	0.997	0.000
T36.8 Other systemic antibiotics	0.003	0.997	0.000
T36.7 Antifungal antibiotics, systemically used	0.003	0.997	0.000
T36.6 Rifamycins	0.003	0.997	0.000
T36.5 Aminoglycosides	0.003	0.997	0.000
T36.4 Tetracyclines	0.003	0.997	0.000
T36.3 Macrolides	0.003	0.997	0.000
T36.2 Chloramphenicol group	0.003	0.997	0.000
T36.1 Cefalosporins and other Beta-lactam antibiotics	0.003	0.997	0.000
T50.2 Carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics	0.003	0.997	0.000
T50.8 Diagnostic agents	0.003	0.997	0.000
T46.1 Calcium-channel blockers	0.003	0.997	0.000
T41.5 Therapeutic gases	0.003	0.997	0.000
T41.4 Anaesthetic, unspecified	0.003	0.997	0.000
T41.3 Local anaesthetics	0.003	0.997	0.000
T41.2 Other and unspecified general anaesthetics	0.003	0.997	0.000
T41.1 Intravenous anaesthetics	0.003	0.997	0.000
T41.0 Inhaled anaesthetics	0.003	0.997	0.000
T45.9 Primarily systemic and haematological agent, unspecified	0.003	0.997	0.000
T45.8 Other primarily systemic and haematological agents	0.003	0.997	0.000
T45.7 Anticoagulant antagonists, vitamin K and other coagulants	0.003	0.997	0.000
T45.6 Fibrinolysis-affecting drugs	0.003	0.997	0.000
T45.4 Iron and its compounds	0.003	0.997	0.000
T45.3 Enzymes, not elsewhere classified	0.003	0.997	0.000
T45.2 Vitamins, not elsewhere classified	0.003	0.997	0.000
D75.1 Secondary polycythaemia	0.000	0.997	0.003
T47 Poisoning by agents primarily affecting gastro-intestinal system	0.003	0.997	0.000
Z08.0 Follow-up examination after surgery for malignant neoplasm	0.003	0.997	0.000
T38 Poisoning by hormones and their synthetic substitutes and antagonists, not elsewhere classified	0.003	0.997	0.000
B24 Unspecified human immunodeficiency virus [HIV] disease	0.003	0.997	0.000
J10.1 Influenza with other respiratory manifestations, influenza virus identified	0.003	0.997	0.000
T44.7 Beta-Adrenoreceeptor antagonists, not elsewhere classified	0.003	0.997	0.000
H18.4 Corneal degeneration	0.000	0.997	0.003
H54.0 Blindness, both eyes	0.000	0.997	0.003
S06.20 Diffuse brain injury (without open intracranial wound)	0.003	0.997	0.000
N87.9 Dysplasia of cervix uteri, unspecified	0.000	0.997	0.003
T45.5 Anticoagulants	0.003	0.997	0.000
Z08 Follow-up examination after treatment for malignant neoplasm	0.003	0.997	0.000
Z71.1 Person with feared complaint in whom no diagnosis is made	0.003	0.997	0.000
E21 Hyperparathyroidism and other disorders of parathyroid gland	0.003	0.997	0.000
H58.8 Visual disturbances in diseases classified elsewhere	0.003	0.997	0.000
H81.1 Benign paroxysmal vertigo	0.000	0.997	0.003
S92.20 Fracture of other tarsal bone(s) (closed)	0.003	0.997	0.000
T43.2 Other and unspecified antidepressants	0.003	0.997	0.000
H80.9 Otosclerosis, unspecified	0.000	0.997	0.003
Z90.2 Acquired absence of lung [part of]	0.003	0.997	0.000
C71.9 Brain, unspecified	0.000	0.997	0.003
E21.1 Secondary hyperparathyroidism, not elsewhere classified	0.002	0.997	0.000
T45.1 Antineoplastic and immunosuppressive drugs	0.002	0.997	0.000
T47.9 Agent primarily affecting the gastro-intestinal system, unspecified	0.002	0.997	0.000
T47.8 Other agents primarily affecting the gastro-intestinal system	0.002	0.997	0.000
T47.7 Emetics	0.002	0.997	0.000
T47.5 Digestants	0.002	0.997	0.000
T47.3 Saline and osmotic laxatives	0.002	0.997	0.000
D41.4 Bladder	0.003	0.997	0.000
S46 Injury of muscle and tendon at shoulder and upper arm level	0.002	0.998	0.000
T38.9 Other and unspecified hormone antagonists	0.002	0.998	0.000
T38.7 Androgens and anabolic congeners	0.002	0.998	0.000
T38.5 Other oestrogens and progestogens	0.002	0.998	0.000
T38.4 Oral contraceptives	0.002	0.998	0.000
T38.2 Antithyroid drugs	0.002	0.998	0.000
T38.0 Glucocorticoids and synthetic analogues	0.002	0.998	0.000
M07.3 Other psoriatic arthropathies	0.000	0.998	0.002
T47.2 Stimulant laxatives	0.002	0.998	0.000
T47.6 Antidiarrhoeal drugs	0.002	0.998	0.000
T47.0 Histamine H(2)-receptor antagonists	0.002	0.998	0.000
R90 Abnormal findings on diagnostic imaging of central nervous system	0.002	0.998	0.000
T42.7 Antiepileptic and sedative-hypnotic drugs, unspecified	0.002	0.998	0.000
T38.8 Other and unspecified hormones and their synthetic substitutes	0.002	0.998	0.000
T47.1 Other antacids and anti-gastric-secretion drugs	0.002	0.998	0.000
E21.3 Hyperparathyroidism, unspecified	0.002	0.998	0.000
T38.1 Thyroid hormones and substitutes	0.002	0.998	0.000
T47.4 Other laxatives	0.002	0.998	0.000
S46.3 Injury of muscle and tendon of triceps	0.002	0.998	0.000
T40 Poisoning by narcotics and psychodysleptics [hallucinogens]	0.002	0.998	0.000
C71.4 Occipital lobe	0.000	0.998	0.002
S46.9 Injury of unspecified muscle and tendon at shoulder and upper arm level	0.002	0.998	0.000
T38.3 Insulin and oral hypoglycaemic [antidiabetic] drugs	0.002	0.998	0.000
K62.0 Anal polyp	0.002	0.998	0.000
O24.0 Pre-existing diabetes mellitus, insulin-dependent	0.002	0.998	0.000
T38.6 Antigonadotrophins. antioestrogens, antiandrogens, not elsewhere classified	0.002	0.998	0.000
Z49.2 Other dialysis	0.002	0.998	0.000
M80.0 Postmenopausal osteoporosis with pathological fracture	0.002	0.998	0.000
M43.16 Spondylolisthesis (Lumbar region)	0.000	0.998	0.002
E83.4 Disorders of magnesium metabolism	0.002	0.998	0.000
H54.1 Blindness, one eye, low vision, other eye	0.000	0.998	0.002
R90.0 Intracranial space-occupying lesion	0.002	0.998	0.000
S46.7 Injury of multiple muscles and tendons at shoulder and upper arm level	0.002	0.998	0.000
M07.35 Other psoriatic arthropathies (Pelvic region and thigh)	0.000	0.998	0.002
E21.5 Disorder of parathyroid gland, unspecified	0.002	0.998	0.000
H54.9 Unspecified visual impairment (binocular)	0.000	0.998	0.002
M07.33 Other psoriatic arthropathies (Forearm)	0.000	0.998	0.002
M07.32 Other psoriatic arthropathies (Upper arm)	0.000	0.998	0.002
E21.2 Other hyperparathyroidism	0.002	0.998	0.000
T40.3 Methadone	0.002	0.998	0.000
K80.4 Calculus of bile duct with cholecystitis	0.000	0.998	0.002
T40.1 Heroin	0.002	0.998	0.000
M07.34 Other psoriatic arthropathies (Hand)	0.000	0.998	0.002
E21.4 Other specified disorders of parathyroid gland	0.002	0.998	0.000
I46.9 Cardiac arrest, unspecified	0.002	0.998	0.000
C71 Malignant neoplasm of brain	0.000	0.998	0.002
H54 Blindness and low vision	0.000	0.998	0.002
R63.8 Other symptoms and signs concerning food and fluid intake	0.000	0.998	0.002
M07.38 Other psoriatic arthropathies (Other)	0.000	0.998	0.002
M07.36 Other psoriatic arthropathies (Lower leg)	0.000	0.998	0.002
M07.31 Other psoriatic arthropathies (Shoulder region)	0.000	0.998	0.002
C71.8 Overlapping lesion of brain	0.000	0.998	0.002
S46.1 Injury of muscle and tendon of long head of biceps	0.002	0.998	0.000
Z08.2 Follow-up examination after chemotherapy for malignant neoplasm	0.002	0.998	0.000
T42 Poisoning by antiepileptic, sedative-hypnotic and anti-Parkinsonism drugs	0.002	0.998	0.000
M07.30 Other psoriatic arthropathies (Multiple sites)	0.000	0.998	0.002
O23.5 Infections of the genital tract in pregnancy	0.002	0.998	0.000
T40.9 Other and unspecified psychodysleptics [hallucinogens]	0.002	0.998	0.000
T40.8 Lysergide [LSD]	0.002	0.998	0.000
T40.7 Cannabis (derivatives)	0.002	0.998	0.000
T40.0 Opium	0.002	0.998	0.000
S22.20 Fracture of sternum (closed)	0.002	0.998	0.000
Q27.3 Peripheral arteriovenous malformation	0.000	0.998	0.002
S83.6 Sprain and strain of other and unspecified parts of knee	0.000	0.998	0.002
T40.5 Cocaine	0.002	0.998	0.000
N20.9 Urinary calculus, unspecified	0.002	0.998	0.000
O28.1 Abnormal biochemical finding on antenatal screening of mother	0.002	0.998	0.000
R93.4 Abnormal findings on diagnostic imaging of urinary organs	0.000	0.998	0.002
M07.37 Other psoriatic arthropathies (Ankle and foot)	0.000	0.998	0.002
H54.2 Low vision, both eyes	0.000	0.998	0.002
M72.27 Plantar fascial fibromatosis-Ankle/Foot	0.000	0.998	0.002
A08.4 Viral intestinal infection, unspecified	0.000	0.998	0.002
H81.2 Vestibular neuronitis	0.000	0.998	0.002
A08.1 Acute gastro-enteropathy due to Norwalk agent	0.000	0.998	0.002
B35.3 Tinea pedis	0.002	0.998	0.000
I98 Other disorders of circulatory system in diseases classified elsewhere	0.000	0.998	0.002
M80.09 Postmenopausal osteoporosis with pathological fracture (Site unspecified)	0.002	0.998	0.000
M80.08 Postmenopausal osteoporosis with pathological fracture (Other)	0.002	0.998	0.000
M80.07 Postmenopausal osteoporosis with pathological fracture (Ankle and foot)	0.002	0.998	0.000
M80.06 Postmenopausal osteoporosis with pathological fracture (Lower leg)	0.002	0.998	0.000
M80.05 Postmenopausal osteoporosis with pathological fracture (Pelvic region and thigh)	0.002	0.998	0.000
M80.04 Postmenopausal osteoporosis with pathological fracture (Hand)	0.002	0.998	0.000
M80.03 Postmenopausal osteoporosis with pathological fracture (Forearm)	0.002	0.998	0.000
M80.02 Postmenopausal osteoporosis with pathological fracture (Upper arm)	0.002	0.998	0.000
M80.01 Postmenopausal osteoporosis with pathological fracture (Shoulder region)	0.002	0.998	0.000
D41.2 Ureter	0.002	0.998	0.000
N87.2 Severe cervical dysplasia, not elsewhere classified	0.000	0.998	0.002
T42.3 Barbiturates	0.002	0.998	0.000
A63.0 Anogenital (venereal) warts	0.002	0.998	0.000
C16.9 Stomach, unspecified	0.000	0.998	0.002
Q27.8 Other specified congenital malformations of peripheral vascular system	0.000	0.998	0.002
C81.9 Hodgkin's disease, unspecified	0.002	0.998	0.000
H54.6 Unqualified visual loss, one eye	0.000	0.998	0.002
O24 Diabetes mellitus in pregnancy	0.002	0.998	0.000
S46.8 Injury of other muscles and tendons at shoulder and upper arm level	0.002	0.998	0.000
C71.0 Cerebrum, except lobes and ventricles	0.000	0.998	0.002
K38.8 Other specified diseases of appendix	0.002	0.998	0.000
O23.9 Other and unspecified genito-urinary tract infection in pregnancy	0.002	0.998	0.000
Z08.9 Follow-up examination after unspecified treatment for malignant neoplasm	0.002	0.998	0.000
Z37.2 Twins, both liveborn	0.000	0.998	0.002
O23 Infections of genito-urinary tract in pregnancy	0.002	0.998	0.000
T39.9 Nonopioid analgesic, antipyretic and antirheumatic, unspecified	0.002	0.998	0.000
K05.3 Chronic periodontitis	0.000	0.998	0.002
C71.6 Cerebellum	0.000	0.998	0.002
H54.3 Unqualified visual loss, both eyes	0.000	0.998	0.002
H90.3 Sensorineural hearing loss, bilateral	0.002	0.998	0.000
I08.1 Disorders of both mitral and tricuspid valves	0.000	0.998	0.002
C71.5 Cerebral ventricle	0.000	0.998	0.002
O28.0 Abnormal haematological finding on antenatal screening of mother	0.002	0.998	0.000
T42.5 Mixed antiepileptics, not elsewhere classified	0.002	0.998	0.000
T42.2 Succinimides and oxazolidinediones	0.002	0.998	0.000
R68.8 Other specified general symptoms and signs	0.002	0.998	0.000
B49 Unspecified mycosis	0.002	0.998	0.000
D41 Neoplasm of uncertain or unknown behaviour of urinary organs	0.002	0.998	0.000
J17.2 Pneumonia in mycoses	0.002	0.998	0.000
B35 Dermatophytosis	0.002	0.998	0.000
H81 Disorders of vestibular function	0.000	0.998	0.002
B44.9 Aspergillosis, unspecified	0.002	0.998	0.000
H80 Otosclerosis	0.000	0.998	0.002
J10 Influenza due to identified influenza virus	0.002	0.998	0.000
Q27 Other congenital malformations of peripheral vascular system	0.000	0.998	0.002
N08.2 Glomerular disorders in blood diseases and disorders involving the immune mechanism	0.002	0.998	0.000
O20.0 Threatened abortion	0.002	0.998	0.000
H81.9 Disorder of vestibular function, unspecified	0.000	0.998	0.002
N87.1 Moderate cervical dysplasia	0.000	0.998	0.002
T42.8 Anti-Parkinsonism drugs and other central muscle-tone depressants	0.001	0.998	0.000
N08 Glomerular disorders in diseases classified elsewhere	0.002	0.998	0.000
O28 Abnormal findings on antenatal screening of mother	0.002	0.998	0.000
T39 Poisoning by nonopioid analgesics, antipyretics and antirheumatics	0.002	0.998	0.000
N00-N08 Glomerular diseases	0.002	0.998	0.000
B35.4 Tinea corporis	0.001	0.998	0.000
D41.0 Kidney	0.002	0.998	0.000
H54.5 Low vision, one eye	0.000	0.998	0.001
I98.8 Other specified disorders of circulatory system in diseases classified elsewhere	0.000	0.998	0.001
I98.1 Cardiovascular disorders in other infectious and parasitic diseases classified elsewhere	0.000	0.998	0.001
I98.0 Cardiovascular syphilis	0.000	0.998	0.001
O24.9 Diabetes mellitus in pregnancy, unspecified	0.001	0.998	0.000
B20-B24 Human immunodeficiency virus [HIV] disease	0.002	0.998	0.000
M79.18 Myalgia (Other)	0.002	0.998	0.000
B35.1 Tinea unguium	0.002	0.998	0.000
C71.2 Temporal lobe	0.000	0.998	0.002
E27.1 Primary adrenocortical insufficiency	0.002	0.998	0.000
O24.4 Diabetes mellitus arising in pregnancy	0.002	0.998	0.000
Q27.9 Congenital malformation of peripheral vascular system, unspecified	0.000	0.998	0.001
R70.0 Elevated erythrocyte sedimentation rate	0.002	0.998	0.000
C71.7 Brain stem	0.000	0.998	0.001
J39.2 Other diseases of pharynx	0.000	0.998	0.002
N08.3 Glomerular disorders in diabetes mellitus	0.002	0.998	0.000
S46.2 Injury of muscle and tendon of other parts of biceps	0.001	0.998	0.000
B20 Human immunodeficiency virus [HIV] disease resulting in infectious and parasitic diseases	0.001	0.998	0.000
B20.6 HIV disease resulting in Pneumocystis carinii pneumonia	0.001	0.998	0.000
L73.8 Other specified follicular disorders	0.002	0.998	0.000
N83.1 Corpus luteum cyst	0.002	0.998	0.000
O24.3 Pre-existing diabetes mellitus, unspecified	0.001	0.998	0.000
O24.2 Pre-existing malnutrition-related diabetes mellitus	0.001	0.998	0.000
O24.1 Pre-existing diabetes mellitus, noninsulin-dependent	0.001	0.998	0.000
T40.4 Other synthetic narcotics	0.001	0.998	0.000
N87 Dysplasia of cervix uteri	0.000	0.998	0.002
O23.3 Infections of other parts of urinary tract in pregnancy	0.001	0.998	0.000
O23.2 Infections of urethra in pregnancy	0.001	0.998	0.000
O23.1 Infections of bladder in pregnancy	0.001	0.998	0.000
O23.0 Infections of kidney in pregnancy	0.001	0.998	0.000
R25.2 Cramp and spasm	0.000	0.998	0.002
C71.1 Frontal lobe	0.000	0.998	0.001
D30.3 Bladder	0.001	0.998	0.000
E27.4 Other and unspecified adrenocortical insufficiency	0.001	0.998	0.000
O23.4 Unspecified infection of urinary tract in pregnancy	0.001	0.998	0.000
S72.40 Fracture of lower end of femur (closed)	0.001	0.999	0.000
F23.9 Acute and transient psychotic disorder, unspecified	0.000	0.999	0.001
G90.0 Idiopathic peripheral autonomic neuropathy	0.001	0.999	0.000
O28.9 Abnormal finding on antenatal screening of mother, unspecified	0.001	0.999	0.000
B35.6 Tinea cruris	0.001	0.999	0.000
D41.9 Urinary organ, unspecified	0.001	0.999	0.000
D41.7 Other urinary organs	0.001	0.999	0.000
D41.3 Urethra	0.001	0.999	0.000
Z08.8 Follow-up examination after other treatment for malignant neoplasm	0.001	0.999	0.000
B35.8 Other dermatophytoses	0.001	0.999	0.000
B35.5 Tinea imbricata	0.001	0.999	0.000
B35.2 Tinea manuum	0.001	0.999	0.000
B35.0 Tinea barbae and tinea capitis	0.001	0.999	0.000
H80.8 Other otosclerosis	0.000	0.999	0.001
H80.2 Cochlear otosclerosis	0.000	0.999	0.001
H80.1 Otosclerosis involving oval window, obliterative	0.000	0.999	0.001
H81.4 Vertigo of central origin	0.000	0.999	0.001
Q27.4 Congenital phlebectasia	0.000	0.999	0.001
Q27.2 Other congenital malformations of renal artery	0.000	0.999	0.001
Q27.1 Congenital renal artery stenosis	0.000	0.999	0.001
Q27.0 Congenital absence and hypoplasia of umbilical artery	0.000	0.999	0.001
S92.2 Fracture of other tarsal bone(s)	0.001	0.999	0.000
S62.60 Fracture of other finger (closed)	0.001	0.999	0.000
J10.8 Influenza with other manifestations, influenza virus identified	0.001	0.999	0.000
E27.8 Other specified disorders of adrenal gland	0.001	0.999	0.000
N08.8 Glomerular disorders in other diseases classified elsewhere	0.001	0.999	0.000
N08.1 Glomerular disorders in neoplastic diseases	0.001	0.999	0.000
N08.0 Glomerular disorders in infectious and parasitic diseases classified elsewhere	0.001	0.999	0.000
O28.8 Other abnormal findings on antenatal screening of mother	0.001	0.999	0.000
O28.5 Abnormal chromosomal and genetic finding on antenatal screening of mother	0.001	0.999	0.000
O28.4 Abnormal radiological finding on antenatal screening of mother	0.001	0.999	0.000
O28.2 Abnormal cytological finding on antenatal screening of mother	0.001	0.999	0.000
R25.8 Other and unspecified abnormal involuntary movements	0.000	0.999	0.001
R25.1 Tremor, unspecified	0.000	0.999	0.001
T39.4 Antirheumatics, not elsewhere classified	0.001	0.999	0.000
T39.2 Pyrazolone derivatives	0.001	0.999	0.000
T42.0 Hydantoin derivatives	0.001	0.999	0.000
B44 Aspergillosis	0.001	0.999	0.000
N07 Hereditary nephropathy, not elsewhere classified	0.001	0.999	0.000
N06 Isolated proteinuria with specified morphological lesion	0.001	0.999	0.000
N01 Rapidly progressive nephritic syndrome	0.001	0.999	0.000
M43.17 Spondylolisthesis (Lumbosacral region)	0.000	0.999	0.001
E89.3 Postprocedural hypopituitarism	0.001	0.999	0.000
H61.0 Perichondritis of external ear	0.000	0.999	0.001
H81.8 Other disorders of vestibular function	0.000	0.999	0.001
I98.3 Oesophageal varices with bleeding in diseases classified elsewhere	0.000	0.999	0.001
Y54.3 Benzothiadiazine derivatives	0.000	0.999	0.001
Z49.0 Preparatory care for dialysis	0.001	0.999	0.000
B22 Human immunodeficiency virus [HIV] disease resulting in other specified diseases	0.001	0.999	0.000
B21 Human immunodeficiency virus [HIV] disease resulting in malignant neoplasms	0.001	0.999	0.000
B20.9 HIV disease resulting in unspecified infectious or parasitic disease	0.001	0.999	0.000
B20.8 HIV disease resulting in other infectious and parasitic diseases	0.001	0.999	0.000
B20.7 HIV disease resulting in multiple infections	0.001	0.999	0.000
B20.5 HIV disease resulting in other mycoses	0.001	0.999	0.000
B20.4 HIV disease resulting in candidiasis	0.001	0.999	0.000
B20.3 HIV disease resulting in other viral infections	0.001	0.999	0.000
B20.2 HIV disease resulting in cytomegaloviral disease	0.001	0.999	0.000
B20.1 HIV disease resulting in other bacterial infections	0.001	0.999	0.000
B20.0 HIV disease resulting in mycobacterial infection	0.001	0.999	0.000
L73.2 Hidradenitis suppurativa	0.001	0.999	0.000
Q28.2 Arteriovenous malformation of cerebral vessels	0.000	0.999	0.001
B23 Human immunodeficiency virus [HIV] disease resulting in other conditions	0.001	0.999	0.000
C71.3 Parietal lobe	0.000	0.999	0.001
D41.1 Renal pelvis	0.001	0.999	0.000
G91.8 Other hydrocephalus	0.000	0.999	0.001
H81.3 Other peripheral vertigo	0.000	0.999	0.001
S06.2 Diffuse brain injury	0.001	0.999	0.000
B35.9 Dermatophytosis, unspecified	0.001	0.999	0.000
M43.1 Spondylolisthesis	0.000	0.999	0.001
N08.4 Glomerular disorders in other endocrine, nutritional and metabolic diseases	0.001	0.999	0.000
Q24.8 Other specified congenital malformations of heart	0.000	0.999	0.001
S70.0 Contusion of hip	0.001	0.999	0.000
H80.0 Otosclerosis involving oval window, nonobliterative	0.000	0.999	0.001
K38.1 Appendicular concretions	0.001	0.999	0.000
Z08.1 Follow-up examination after radiotherapy for malignant neoplasm	0.001	0.999	0.000
T58 Toxic effect of carbon monoxide	0.001	0.999	0.000
S92.21 Fracture of other tarsal bone(s) (open)	0.001	0.999	0.000

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

Variant-specific associations